The Greater Birmingham region is located in the very centre of the UK, anchored by Birmingham; a dynamic and ambitious city, the biomedical and medtech community is the rising star in worldwide life science destinations. Perfect for expanding companies in the Life Sciences industry, the region combines extensive research and development facilities, strong collaboration between academia and business as well as one of Europe’s largest, most diverse and non-transient patient populations.
With state-of-the-art clinical facilities, population scale and diversity and pioneering partnerships between academics and clinicians, Greater Birmingham is truly at the cutting edge of medical technology and global healthcare.
The region is going through an unprecedented period of transformation, and is leading post recession national growth and development trends. With record levels of infrastructure investment, increasing international recognition and countless opportunities for companies to thrive in the region, there has never been a better time to invest in Greater Birmingham.
Business Birmingham are inward investment agencies working together to attract foreign direct investment and promote development in the area as part of the European Regional Development Fund (ERDF) Investing in Greater Birmingham programme, on behalf of the Greater Birmingham and Solihull Local Enterprise Partnership (GBSLEP).
The core of our life science region is situated a few minutes south of the city centre, by train, car or bus, and contains the majority of our centres of excellence and key life science assets. You can walk between all locations in 15 minutes!
In the wider region you can access academics, business and clinicians within an hour by train or car.
The proximity of all our key strengths enables collaboration and accelerates growth.
For further information on the Life Sciences cluster and culture of Greater Birmingham, the Business Birmingham Life Sciences brochure is packed with information about the sector.
Close to the University of Birmingham and the Queen Elizabeth Hospital Birmingham, development is underway for a cutting edge Life Sciences Campus. This will create up to 50,000sqm of new floor space across a number of 3-4 storey buildings in a campus setting, providing a high quality environment for new and growing businesses.
The space will be suitable for research and development, clinical trials, pharmaceutical manufacturing and regional headquarters; an ideal expansion destination for SMEs from around the world.
The Life Sciences Campus is located within an internationally- recognised clinical academic community whose competitive advantages are unrivalled in the UK with the successful commercialisation of healthcare innovation.
It will facilitate SMEs and large pharma and biotechnology firms to work more closely with clinicians and academics, and create an effective entry for industry partners e.g. Pharma, Diagnostics, Medical Devices and Digital Health into the complex world of healthcare research and routes to market.
The wider Edgbaston area already provides a world class centre of scientific excellence with a proliferation of hospitals, medical organisations, specialist care centres, GP clinics and routine care facilities as well as training facilities.
Located at the heart of Greater Birmingham’s Life Sciences campus, the Institute of Translational Medicine (ITM) is a world class facility that capitalises on Birmingham being one of the few centres internationally that can provide a bespoke multidisciplinary translational environment for development and delivery of stratified medicine, clinical trials, rare diseases, biomarkers and device evaluation.
It will facilitate the swift assessment of cost-effective new drugs and medical devices to bring them to market faster and to frontline use within clinical settings. The ITM is expected to support the creation of 600 new jobs within the research community in its first five years.
The ITM is being delivered by Birmingham Health Partners, a collaboration that brings together the clinical, scientific and academic excellence of University Hospitals Birmingham NHS Foundation Trust (UHB), the University of Birmingham (UoB) and Birmingham Children’s Hospital NHS Foundation Trust (BCH), and Birmingham Women’s Hospital (BWH).
As a central meeting point and working hub, it will allow clinicians, academics, bioinformaticians, patient groups and industry leaders to maximise interaction and develop productive collaborative networks.
Calthorpe Estates is one of the UK’s most forward-thinking and progressive property investment and development companies. Family-owned since 1717, the prime focus of the business is the prestigious Calthorpe Estate which offers medical and clinical accommodation ranging from new build clinics through to medical suites and individual consulting rooms.
Home to over 550 medical companies, more than any other region in the country, Edgbaston Medical Quarter is fast developing an international reputation for medical excellence. Many are at the cutting edge of world-class medical technology and provide a base for leading students and practitioners from the UK’s most important medical facilities.
As a dedicated centre for healthcare and life sciences, the estate covers 610 hectares in Edgbaston, with its Pebble Mill site located only 1 mile from the University of Birmingham, Queen Elizabeth Hospital Birmingham and the new Life Science Campus in Selly Oak.
Close to Birmingham’s city centre, this thriving commercial and residential district also incorporates one of the UK’s largest urban conservation areas. Edgbaston is an ideal location for SME companies who need to access a clinical base for product development, clinical trials or procurement routes.
Home to 64% of the city’s healthcare economy, the Edgbaston Medical Quarter boasts 180 medical organisations, 23 training facilities allied to medicine, 44 GP clinics and routine care facilities and 80 hospitals and specialist care centres.
Birmingham Research Park is a thriving community of medical and biomedical activity. Based at the University of Birmingham, the park’s flagship offering is The BioHub Birmingham®; a fully serviced biomedical laboratory and vibrant innovation office designed to provide entrepreneurs and start-ups with access to affordable facilities and equipment. The new facility has been enabled by a £7 million investment by the ERDF, University of Birmingham and Birmingham City Council.
At the heart of the burgeoning healthcare cluster, the 27 acre site currently comprises the Birmingham Dental Hospital and School of Dentistry, a BUPA Care Home, and a new Circle Health Private Hospital, bringing industry and academia together into a hub of collaboration and best practice across clinical and medical platforms.
This £50 million project is the first integrated dental hospital and school built in the UK for almost 40 years and offers 154 dental chairs. It is equipped to treat over 120,000 patients a year and provides world class learning and research facilities for more than 600 students. It offers a wide range of clinical services including emergency dental care, restorative dentistry, oral surgery and medicine, orthodontics and paediatric dentistry.
The planned central super hospital involves £300 million worth of public and private investment generating greater opportunities surrounding medical technology, staffing, sub-contracting and research. The hospital site will span 16 acres, and provide 670 beds and will expand on the services currently offered by Sandwell and West Birmingham Hospitals NHS Trust, whilst the concentration of acute specialist care will attract and retain highly skilled clinicians to the region. The hospital is on schedule for opening late 2018 and is a testament to the quality of the scientific and medical environment in Greater Birmingham.
The West Midlands Academic Health Science Network (WMAHSN) leads, catalyses and drives co-operation, collaboration and productivity between academia, industry, health and care providers and commissioners, and citizens, and accelerates the adoption of innovation to generate continuous improvement in the region’s health and wealth.
On behalf the West Midlands’ population, WMAHSN’s mission is to deliver improved healthcare outcomes and create economic growth by the spread of proven innovations at scale and pace regionally, nationally and internationally.
MediLink WM, a membership organisation with a remit to stimulate growth and innovation in the medical and health technology sector, operates as the Industry Gateway for WMAHSN.
The WMAHSN is one of 15 AHSNs across England, and is located within the Institute of Translational Medicine.”